[Epidemiology and clinical effect against "beta-lactam antibiotic induced vancoymcin-resistant MRSA (BIVR)"].
Hanaki
Hideaki
H
D004336:Drug Antagonism; D016106:Methicillin Resistance; D013211:Staphylococcus aureus / Q000187:drug effects* / Q000302:isolation & purification*; D017334:Teicoplanin / Q000494:pharmacology; D014640:Vancomycin / Q000494:pharmacology; D020713:Vancomycin Resistance / Q000187:drug effects*; D047090:beta-Lactams / Q000494:pharmacology*
D047090:beta-Lactams; D017334:Teicoplanin; D014640:Vancomycin